Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 52, Pages E5088-E5097
Publisher
Proceedings of the National Academy of Sciences
Online
2013-12-06
DOI
10.1073/pnas.1312515110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes
- (2013) Mieko Tsuji et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Suppression of Arterial Thrombosis Without Affecting Hemostatic Parameters With a Cell-Penetrating PAR1 Pepducin
- (2012) Ping Zhang et al. CIRCULATION
- Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development
- (2012) Katie O'Callaghan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Simple Method for Quantifying Functional Selectivity and Agonist Bias
- (2011) Terry Kenakin et al. ACS Chemical Neuroscience
- Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer
- (2011) Jaroslaw Cisowski et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
- (2011) Eric Reiter et al. Annual Review of Pharmacology and Toxicology
- Significant mobilization of both conventional and regulatory T cells with AMD3100
- (2011) L. S. Kean et al. BLOOD
- Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia
- (2011) K. O'Callaghan et al. BLOOD
- Biased signalling and allosteric machines: new vistas and challenges for drug discovery
- (2011) Terry P Kenakin BRITISH JOURNAL OF PHARMACOLOGY
- Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases
- (2011) Won-Tak Choi et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors
- (2011) Wayne Stallaert et al. Expert Opinion on Drug Discovery
- Direct Interaction between an Allosteric Agonist Pepducin and the Chemokine Receptor CXCR4
- (2011) Jay M. Janz et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
- (2011) M Mohty et al. LEUKEMIA
- The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: Implication of the protease-activated receptor-2
- (2011) Herve Y. Sroussi et al. MOLECULAR IMMUNOLOGY
- Quantifying Ligand Bias at Seven-Transmembrane Receptors
- (2011) S. Rajagopal et al. MOLECULAR PHARMACOLOGY
- Subtype Differences in Pre-Coupling of Muscarinic Acetylcholine Receptors
- (2011) Jan Jakubík et al. PLoS One
- Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins
- (2011) L. M. Sevigny et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Synthetic Biology Approach Reveals a CXCR4-G13-Rho Signaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells
- (2011) H. Yagi et al. Science Signaling
- Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment
- (2011) Jonathan Hoggatt et al. Stem Cell Research & Therapy
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
- (2010) A. Agarwal et al. CANCER RESEARCH
- Combining resonance energy transfer methods reveals a complex between the α2A-adrenergic receptor, Gαi1β1γ2, and GRK2
- (2010) Billy Breton et al. FASEB JOURNAL
- Activation of human monocytes by a formyl peptide receptor 2-derived pepducin
- (2010) Ha Young Lee et al. FEBS LETTERS
- Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 Signaling
- (2010) John M. Busillo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2α-mediated Rho/ROCK Signaling Pathway
- (2010) Eugénie Goupil et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells
- (2010) B. Tchernychev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
- (2010) B. Wu et al. SCIENCE
- The Ins and Outs of Hematopoietic Stem Cells: Studies to Improve Transplantation Outcomes
- (2010) Leah A. Marquez-Curtis et al. Stem Cell Reviews and Reports
- Therapeutic potential of β-arrestin- and G protein-biased agonists
- (2010) Erin J. Whalen et al. TRENDS IN MOLECULAR MEDICINE
- Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion
- (2009) R. Kaufmann et al. CARCINOGENESIS
- Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
- (2008) S. M. Devine et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started